OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Clinical Trials
499
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (409 trials with phase data)• Click on a phase to view related trials
A Trial of Centanafadine Efficacy and Safety in Adults With Attention-deficit/Hyperactivity Disorder and Comorbid Anxiety
- Conditions
- ADHDAnxietyGeneralized AnxietySocial Anxiety Disorder
- Interventions
- Other: Placebo
- First Posted Date
- 2025-05-15
- Last Posted Date
- 2025-05-31
- Target Recruit Count
- 308
- Registration Number
- NCT06973577
- Locations
- 🇺🇸
Clinical Research Site #017 - Harmonex Neuroscience Research, Dothan, Alabama, United States
🇺🇸Clinical Research Site #011 - NRC Research Institute, Orange, California, United States
🇺🇸Clinical Research Site #005 - Clinical Neuroscience Solutions, Inc., Jacksonville, Florida, United States
A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)
- Conditions
- Phenylketonuria
- Interventions
- Drug: JNT-517 Tablet
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-06-03
- Target Recruit Count
- 120
- Registration Number
- NCT06971731
A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-07-10
- Target Recruit Count
- 80
- Registration Number
- NCT06928142
- Locations
- 🇺🇸
Medvin Clinical Research - Riverside, Riverside, California, United States
🇺🇸Medvin Clinical Research - Tujunga, Tujunga, California, United States
🇺🇸Bay Area Arthritis and Osteoporosis, Brandon, Florida, United States
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-05-18
- Target Recruit Count
- 522
- Registration Number
- NCT06894212
- Locations
- 🇺🇸
Pillar Clinical Research LLC - Bentonville Site # 145, Bentonville, Arkansas, United States
🇺🇸Pillar Clinical Research (Little Rock AR) Site #153, Little Rock, Arkansas, United States
🇺🇸Woodland International Research Group Site #141, Little Rock, Arkansas, United States
A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-27
- Target Recruit Count
- 264
- Registration Number
- NCT06795399
- Prev
- 1
- 2
- 3
- 4
- 5
- 51
- Next